Fig. 3.

Forest Plot of univariate logistic regressions for patient preference to s.c. versus i.v./no preference trastuzumab, CT appt, chemotherapy appointments (place where the chemotherapy was applied); i.v., intravenous; PINT1, patient interview at timepoint 1 = 20 to −1 days prior to randomization; s.c., subcutaneous.